{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:18:21Z","timestamp":1789492701719,"version":"build-2803163510"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the use of povidone-iodine infusion during pars plana vitrectomy and to assess its clinical outcomes in the treatment of severe endophthalmitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective case series of 40 patients (41 eyes) with clinically or culture-confirmed endophthalmitis underwent pars plana vitrectomy with 0.025% povidone-iodine in the infusion solution. Outcomes included infection resolution, improvements in visual acuity, the need for additional surgeries, and signs of ocular toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 41 eyes treated, infection resolved in 33 (80.4%) eyes postoperatively. Visual acuity improved postoperatively in 29 eyes (70.7%). Mean uncorrected visual acuity improved from 20\/3,337 (2.22 \u00b1 0.70 logMAR) preoperatively to 20\/540 (1.43 \u00b1 0.88 logMAR) postoperatively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). No ocular toxicity or unexplained vision loss related to povidone-iodine infusion was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The addition of 0.025% povidone-iodine infusion during pars plana vitrectomy appears safe and led to favorable post-surgical outcomes in a traditionally high-risk cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004748","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T22:00:29Z","timestamp":1767391229000},"page":"855-862","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["INTRAOCULAR POVIDONE-IODINE DURING PARS PLANA VITRECTOMY FOR SEVERE AND ATYPICAL ENDOPHTHALMITIS"],"prefix":"10.1097","volume":"46","author":[{"given":"Kavon","family":"Rahmani","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Saad","sequence":"additional","affiliation":[{"name":"Kresge Eye Institute, Detroit, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Henry Ford Hospital, Detroit, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihui","family":"Lin","sequence":"additional","affiliation":[{"name":"Kresge Eye Institute, Detroit, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0161-6420(98)94028-3","article-title":"Additional procedures after the initial vitrectomy or tap-biopsy in the endophthalmitis vitrectomy study","volume":"105","author":"Doft","year":"1998","journal-title":"Ophthalmology"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/09273948.2020.1826539","article-title":"Comparative outcomes of primary vitrectomy versus tap and inject for endophthalmitis following phacoemulsification cataract surgery","volume":"30","author":"Crosby","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/24741264241275246","article-title":"Unified approach to treating exogenous endophthalmitis with immediate vitrectomy","volume":"8","author":"Loh","year":"2024","journal-title":"J Vitreoretin Dis"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"952375","DOI":"10.3389\/fcell.2022.952375","article-title":"Endophthalmitis at a tertiary referral center: characteristics and treatment outcomes over three decades","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00417-019-04480-2","article-title":"Clinical and visual outcome of endophthalmitis patients: a single-center experience","volume":"258","author":"Kitsche","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.4103\/ijo.IJO_2640_21","article-title":"Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis","volume":"70","author":"Bari","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41433-025-03673-w","article-title":"Long term analysis of microbiological isolates and antibiotic susceptibilities in acute-onset postoperative endophthalmitis: a UK multicentre study","volume":"39","author":"Teh","year":"2025","journal-title":"Eye"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICU.0000000000000437","article-title":"The use of povidone\u2013iodine in ophthalmology","volume":"29","author":"Grzybowski","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"107116","DOI":"10.1016\/j.ijid.2024.107116","article-title":"Endogenous endophthalmitis: new insights from a 12-year cohort study","volume":"146","author":"Dedieu","year":"2024","journal-title":"Int J Infect Dis"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0255-0857.180280","article-title":"Microbial profile of the vitreous aspirates in culture proven exogenous endophthalmitis: a 10-year retrospective study","volume":"34","author":"Bhattacharjee","year":"2016","journal-title":"Indian J Med Microbiol"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/IAE.0b013e318228e312","article-title":"Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea","volume":"32","author":"Lee","year":"2012","journal-title":"Retina"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"257","DOI":"10.18502\/jovr.v14i3.4781","article-title":"Outbreak of multidrug-resistant Pseudomonas aeruginosa endophthalmitis due to contaminated trypan blue solution","volume":"14","author":"Bawankar","year":"2019","journal-title":"J Ophthalmic Vis Res"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/jcm12020502","article-title":"Visual outcomes and prognostic factors of traumatic endophthalmitis treated by pars plana vitrectomy: 11 years retrospective analysis","volume":"12","author":"Hapca","year":"2023","journal-title":"J Clin Med"},{"key":"R15-20260915","first-page":"e65974","article-title":"Presenting characteristics, treatment, and visual outcomes in streptococcal compared to non-streptococcal endophthalmitis","volume":"16","author":"Woodward","year":"2024","journal-title":"Cureus"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/ceo.13477","article-title":"Bleb-associated endophthalmitis: proportion, presentation, management and outcomes in Victoria, Australia","volume":"47","author":"Kwon","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ophtha.2004.01.028","article-title":"Bleb-associated endophthalmitis: clinical characteristics and visual outcomes","volume":"111","author":"Busbee","year":"2004","journal-title":"Ophthalmology"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/antibiotics12081246","article-title":"Role of antimicrobial resistance in outcomes of acute endophthalmitis","volume":"12","author":"Yap","year":"2023","journal-title":"Antibiotics"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.oret.2019.05.017","article-title":"Visual acuity outcomes and anti-vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world analysis of 49 485 eyes","volume":"4","author":"Ciulla","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0002-9610(86)90477-0","article-title":"Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions","volume":"151","author":"Zamora","year":"1986","journal-title":"Am J Surg"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02713689008999567","article-title":"Tolerance of intravitreal povidone-iodine in rabbit eyes","volume":"9","author":"Whitacre","year":"1990","journal-title":"Curr Eye Res"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000217721","article-title":"The efficacy of intravitreal povidone iodine application in experimental Staphylococcus epidermidis endophthalmitis","volume":"41","author":"Brozou","year":"2009","journal-title":"Ophthalmic Res"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1167\/iovs.15-17739","article-title":"Intraocular pharmacokinetics of povidone-iodine and its effects on experimental Staphylococcus epidermidis endophthalmitis","volume":"56","author":"Kim","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/IAE.0000000000000634","article-title":"Vitrectomy using 0.025% povidone-iodine in balanced salt solution plus for the treatment of postoperative endophthalmitis","volume":"35","author":"Nakashizuka","year":"2015","journal-title":"Retina"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/tvst.8.1.21","article-title":"Intravitreal injection of 1.25% povidone iodine followed by vitrectomy using 0.025% povidone iodine irrigation for treating endophthalmitis","volume":"8","author":"Nakashizuka","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3928\/23258160-20210820-01","article-title":"Intraocular povidone iodine during pars plana vitrectomy for severe and atypical endophthalmitis","volume":"52","author":"Mi","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R29-20260915","first-page":"95","article-title":"Endogenous endophthalmitis caused by Escherichia coli","volume":"25","author":"Park","year":"1993","journal-title":"Ann Ophthalmol"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2147\/OPTH.S535966","article-title":"Two-decade retrospective analysis of postoperative endophthalmitis at a tertiary care academic center: microbial spectrum, treatment modalities, and visual outcomes","volume":"19","author":"Kritfuangfoo","year":"2025","journal-title":"Clin Ophthalmol (Auckland)"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/IAE.0000000000001358","article-title":"Microbiologic spectrum and visual outcomes of acute-onset endophthalmitis undergoing therapeutic pars plana vitrectomy","volume":"37","author":"Sridhar","year":"2017","journal-title":"Retina"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMra2216081","article-title":"Eye infections","volume":"389","author":"Durand","year":"2023","journal-title":"N Engl J Med"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1038\/s41598-020-69251-0","article-title":"Clinicomicrobiological profile, visual outcome and mortality of culture-proven endogenous endophthalmitis in Taiwan","volume":"10","author":"Hsieh","year":"2020","journal-title":"Sci Rep"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/eye.2010.145","article-title":"Endogenous endophthalmitis: 10-year experience at a tertiary referral centre","volume":"25","author":"Connell","year":"2011","journal-title":"Eye"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.survophthal.2014.06.002","article-title":"Systematic review of 342 cases of endogenous bacterial endophthalmitis","volume":"59","author":"Jackson","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.ophtha.2015.04.036","article-title":"Characteristics of endophthalmitis after cataract surgery in the United States medicare population","volume":"122","author":"Gower","year":"2015","journal-title":"Ophthalmology"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ophtha.2018.01.022","article-title":"Endophthalmitis after intravitreal injection of vascular endothelial growth factor inhibitors: management and visual outcomes","volume":"125","author":"Xu","year":"2018","journal-title":"Ophthalmology"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/ceo.13077","article-title":"Predictors of visual outcome and the role of early vitrectomy in streptococcal endophthalmitis","volume":"46","author":"Kurniawan","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00417-005-0082-8","article-title":"Ten years after\u2026 are findings of the endophthalmitis vitrectomy study still relevant today?","volume":"243","author":"Kuhn","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"e000423","DOI":"10.1136\/bmjophth-2019-000423","article-title":"Vitrectomy for endophthalmitis: 5-year study of outcomes and complications","volume":"5","author":"Negretti","year":"2020","journal-title":"BMJ Open Ophthalmol"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/bjo.2010.189407","article-title":"Povidone-iodine application induces corneal cell death through fixation","volume":"95","author":"Chou","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/archopht.118.12.1661","article-title":"Retinal detachment in the endophthalmitis vitrectomy study","volume":"118","author":"Doft","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1167\/iovs.11-9114","article-title":"Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections","volume":"53","author":"Hou","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/ceo.13768","article-title":"Gram-negative endophthalmitis: a prospective study examining the microbiology, clinical associations and visual outcomes following infection","volume":"48","author":"Stevenson","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"R45-20260915","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/IAE.0000000000000162","article-title":"Endophthalmitis caused by klebsiella species","volume":"34","author":"Sridhar","year":"2014","journal-title":"Retina"},{"key":"R46-20260915","doi-asserted-by":"crossref","first-page":"31104","DOI":"10.1038\/srep31104","article-title":"Electroretinographic evaluations of retinal function before, just after, and after intravitreal injections","volume":"6","author":"Yagura","year":"2016","journal-title":"Sci Rep"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:00:43Z","timestamp":1789491643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004748","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}